P Scheltens

发表

Qualitative Assessment of Cerebral Atrophy on MRI: Inter- and Intra-Observer Reproducibility in Dementia and Normal Aging

F Barkhof, P. Scheltens, D. Leys, 1997, European Neurology.

Medial temporal lobe atrophy on MRI in dementia with Lewy bodies

I G McKeith, J T O'Brien, P. Scheltens, 1999, Neurology.

Visual association encoding activates the medial temporal lobe: A functional magnetic resonance imaging study

F Barkhof, W C Machielsen, S A Rombouts, 1997, Hippocampus.

Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study

M J Firbank, J T O'Brien, P. Scheltens, 2009, Psychological Medicine.

A new rapid landmark-based regional MRI segmentation method of the brain

P. Scheltens, A. Bokde, H. Hampel, 2002, Journal of the Neurological Sciences.

Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease

Nick C Fox, F Barkhof, N C Fox, 2009, Neurology.

Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment

W. M. van der Flier, M. Nöthen, F. Jessen, 2016, Molecular Psychiatry.

Hippocampal sulcus width and cavities: comparison between patients with Alzheimer disease and nondemented elderly subjects.

F Barkhof, P. Scheltens, F. Barkhof, 2006, AJNR. American journal of neuroradiology.

Functional and effective whole brain connectivity using magnetoencephalography to identify monozygotic twin pairs

D I Boomsma, B W van Dijk, A Hillebrand, 2017, Scientific Reports.

Diagnosing Alzheimer's disease in community-dwelling elderly: a comparison of EEG and MRI.

P. Scheltens, R. Strijers, E. Jonkman, 1997, Dementia and geriatric cognitive disorders.

Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer’s disease

F Barkhof, S. Rombouts, P. Scheltens, 2002, Journal of neurology, neurosurgery, and psychiatry.

Visual Rating of Age-Related White Matter Changes on Magnetic Resonance Imaging: Scale Comparison, Interrater Agreement, and Correlations With Quantitative Measurements

O Almkvist, P Kapeller, F Fazekas, 2003, Stroke.

White Matter Changes Contribute to Corpus Callosum Atrophy in the Elderly: The LADIS Study

F Fazekas, O B Paulson, F Barkhof, 2008, American Journal of Neuroradiology.

rCBF SPECT in Parkinson's disease patients with mental dysfunction.

P. Scheltens, E. Wolters, P. Scheltens, 1997, Journal of neural transmission. Supplementum.

MRI volumetric correlates of white matter lesions in dementia with lewy bodies and Alzheimer's disease

I G McKeith, J T O'Brien, P. Scheltens, 2000, International journal of geriatric psychiatry.

Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD

F Barkhof, S. Rombouts, P. Scheltens, 2003, Neurology.

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

W. M. van der Flier, K. Blennow, P. Scheltens, 2009, Annals of clinical biochemistry.

[Cerebral white matter lesions in the elderly: vascular risk factors and cognitive consequences].

P Scheltens, H C Weinstein, B van Harten, 2002, Nederlands tijdschrift voor geneeskunde.

Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study

I G McKeith, J T O'Brien, R H Perry, 1999, Psychological Medicine.

Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts.

F Barkhof, P. Scheltens, D. Leys, 1996, European neurology.

Epidemiology and risk factors of dementia

W. M. van der Flier, P. Scheltens, W. Flier, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Whole-brain atrophy rate in Alzheimer disease

Nick C Fox, F Barkhof, N C Fox, 2008, Neurology.

Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer’s disease

F Barkhof, P. Scheltens, F. Barkhof, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Age and diagnostic performance of Alzheimer disease CSF biomarkers

J Schröder, W. M. van der Flier, K. Blennow, 2012, Neurology.

Physical activity and white matter lesion progression

L H Kuller, P. Scheltens, L. Kuller, 2007, Neurology.

White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes.

F Fazekas, F Barkhof, J Bowler, 1998, European neurology.

Nonlinear Changes in Brain Activity During Continuous Word Repetition: An Event-Related Multiparametric Functional MR Imaging Study

F Barkhof, M P Witter, P Scheltens, 2007, American Journal of Neuroradiology.

Research criteria for subcortical vascular dementia in clinical trials.

G C Roman, P. Scheltens, H. Chui, 2000, Journal of neural transmission. Supplementum.

Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study

F Fazekas, F Barkhof, E Rostrup, 2007, Diabetic medicine : a journal of the British Diabetic Association.

Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study

P Julin, P. Scheltens, L. Wahlund, 2000, Journal of neurology, neurosurgery, and psychiatry.

EFNS guidelines for the diagnosis and management of Alzheimer’s disease

J T O'Brien, G Gainotti, P. Scheltens, 2010, European journal of neurology.

Visualizing brain activation during planning: the tower of London test adapted for functional MR imaging.

F Barkhof, W C Machielsen, S A Rombouts, 2000, AJNR. American journal of neuroradiology.